Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452490 · ClinicalTrials.gov registry record · NA
Diode Laser Treatment of Onychomycosis
A NA study of Onychomycosis, sponsored by ConBio, a Cynosure Company.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT01452490: Completed NA study of Onychomycosis, sponsored by ConBio, a Cynosure Company.
NCT01452490 is a NA study of Onychomycosis that has completed, run by ConBio, a Cynosure Company. The registered enrollment target is 50 participants, below the 90-participant average among 11 other Onychomycosis trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01452490, a NA study of Onychomycosis, has completed, sponsored by ConBio, a Cynosure Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the V-Raser diode laser system with investigational Nail Fungus Handpiece in the treatment of onychomycosis.
Primary Outcome
Amount of lesion-free toenail growth (mm or total area of involvement) from Baseline, as judged by computer software analysis of photos.
Conditions Studied
Interventions
- DEVICE Diode Laser Treatment
Study Locations (2)
Connecticut
- Shoreline Foot and Ankle Center - New London
- Shoreline Foot and Ankle Center - Westbrook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01452490 record still lists
NCT01452490 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 90-participant average among 11 other Onychomycosis trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Diode Laser Treatment is the first listed.
NCT01452490 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01452490 about?
NCT01452490 is a clinical study titled "Diode Laser Treatment of Onychomycosis". The purpose of this study is to evaluate the V-Raser diode laser system with investigational Nail Fungus Handpiece in the treatment of onychomycosis.
What is the current status of trial NCT01452490?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2013-08.
What conditions does trial NCT01452490 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT01452490?
The interventions under investigation include: Diode Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT01452490?
This trial is sponsored by ConBio, a Cynosure Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01452490 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01452490's enrollment target sits among peer trials
50 4th of 11 higher than 7 of 11 other Onychomycosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Onychomycosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
COMPLETED · NA
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia